New: a trial court in 1 of every 10 U.S. counties. Read the post
Court Rules
All enforcement actions
SettlementLow RiskMultistate

Multistate Generic Drug Price-Fixing Settlement Distribution

Glenmark, Lannett, Bausch, Apotex, Heritage, and EmcureSeptember 22, 2026Connecticut Attorney General

Summary

Connecticut and a coalition of 47 other states and territories announced preliminary court approval of a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to inflate drug prices. The release does not give the date of the court’s preliminary approval, so the event date reflects the press release date.

Remedy

The approved distribution plan is intended to return settlement funds to eligible consumers who purchased specified generic drugs between May 2009 and December 2019. The manufacturers’ settlements totaled approximately $96.5 million.

Consumer Refunds

Contract Impact

Review vendor, distribution, and customer agreements for terms that could facilitate coordination with competitors, including exchanges of nonpublic pricing, market-allocation arrangements, or restrictions on independent pricing decisions. Check pharmaceutical supply and distribution contracts for clear independent-pricing obligations, limits on sharing competitively sensitive information, and audit rights supporting antitrust compliance. Employee and consultant agreements and policies should also address competitor-contact rules, trade association participation, escalation of suspected collusion, and cooperation with investigations.

Contract Search Terms

competitor communications restrictionsprice coordination prohibitionantitrust compliance representationstrade association participation rulesinformation exchange restrictionspricing data access controlsemployee antitrust trainingaudit and investigation cooperation

Violation Types

Entity Details

Entity

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

Industry

Healthcare

Multistate Coalition

Attorneys General of 47 other states and territories

Official Sources

Source Evidence

Entity Name
"The coalition previously announced settlements with the manufacturers Glenmark, Lannett, Bausch, Apotex, Heritage, and Heritage’s parent company, Emcure"
Remedy Summary
"totaling approximately $96.5 million"
Violation description
"defendants used terms like "fair share," "playing nice in the sandbox," and "responsible competitor" to unlawfully discourage competition, raise prices, and enforce an ingrained culture of collusion."
Is Multistate
"Attorney General Tong, along with the Attorneys General of 47 other states and territories"
Event Date
"09/22/2026"

Related Enforcement Actions

OR

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

$96.5M

Oregon and a multistate coalition announced a plan to distribute settlement funds to people who paid inflated prices for certain generic drugs. The release says a federal court granted preliminary approval of the distribution plan this month; it does not give the date of that approval, and the reported conduct concerns alleged antitrust violations rather than a privacy violation.

NJ

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

$96.5M

New Jersey and a coalition of states and territories obtained preliminary approval for a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to raise drug prices. The settlements total approximately $96.5 million, and eligible consumers may submit claims for compensation.

CT

Frontier Communications Parent Inc.

$625K

Connecticut reached a $625,000 settlement with Frontier Communications Parent Inc. over an April 2024 breach in which compromised employee and vendor credentials were used to access internal systems and exfiltrate unencrypted personal information of 58,841 Connecticut residents. The settlement requires Frontier to strengthen its security program, implement specific safeguards and training, and obtain an independent third-party assessment.

CT

Boston Children’s Health Physicians and XTIUM

$2.6M

Connecticut and New York found that Boston Children’s Health Physicians and its security vendor, XTIUM, failed to use reasonable safeguards, resulting in hackers accessing sensitive personal, medical, and employee information. The companies agreed to pay penalties totaling $2.64 million and implement enhanced cybersecurity measures.

CT

Character Technologies, Inc.

Connecticut joined a coalition of state attorneys general filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive information it holds. The states seek protections for children and consumers if the company’s business or assets are sold or transferred; the filing does not impose a fine or other remedy.

CT

Connecticut public utilities

Attorney General William Tong and Consumer Counsel Claire Coleman petitioned PURA to review how Connecticut public utilities use artificial intelligence, citing potential data privacy and cybersecurity risks, algorithmic errors, and misleading outputs. The petition asks PURA to examine utility AI systems, safeguards, vendors, and data security practices; it does not report a finding of violation or an imposed penalty.